DIN 02455102 — TALTZ 80 MG
TALTZ is a solution of Ixekizumab marketed by ELI LILLY CANADA INC. The full Ixekizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02455102
- Brand name
- TALTZ
- Active ingredient
- Ixekizumab
- Strength
- 80 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- ELI LILLY CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Interleukin-17A (IL-17A) inhibitor (monoclonal antibody / immunomodulator)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ixekizumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02455110 | TALTZ | 80 MG | SOLUTION | ELI LILLY CANADA INC | MARKETED |